Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Megan M. Martin"'
Autor:
Karen S. Ho, E. Robert Wassman, Adrianne L. Baxter, Charles H. Hensel, Megan M. Martin, Aparna Prasad, Hope Twede, Rena J. Vanzo, Merlin G. Butler
Publikováno v:
International Journal of Molecular Sciences, Vol 17, Iss 12, p 2070 (2016)
Copy number variants (CNVs) detected by chromosomal microarray analysis (CMA) significantly contribute to understanding the etiology of autism spectrum disorder (ASD) and other related conditions. In recognition of the value of CMA testing and its im
Externí odkaz:
https://doaj.org/article/2330efd86d5e43a294040be62ec7a272
Autor:
Aparna Prasad, Megan M. Martin, E. Robert Wassman, Rena Vanzo, Sarah T. South, Karen S. Ho, Hope Twede
Publikováno v:
European Journal of Medical Genetics. 62:15-20
Copy number variants (CNV)s involving KANK1 are generally classified as variants of unknown significance. Several clinical case reports suggest that the loss of KANK1 on chromosome 9p24.3 has potential impact on neurodevelopment. These case studies a
Autor:
Moises A. Serrano, Hom Y, Rena Vanzo, Bilancia Cg, Davis Kw, Megan M. Martin, Mohammed Uddin, Rimmasch M
To identify and prioritize candidate disease genes of the central nervous system (CNS) we created the Neurogenetic Systematic Correlation of Omics-Related Evidence (NeuroSCORE). We used five genome-wide metrics highly associated with neurological phe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::708827c17e1945c0071693ee645045ed
https://doi.org/10.1101/2021.02.04.429640
https://doi.org/10.1101/2021.02.04.429640
Autor:
Yolanda Hom, Kyle W. Davis, Megan M. Martin, Mohammed Uddin, Moises A. Serrano, Colleen Bilancia, Megan Rimmasch, Rena Vanzo
Publikováno v:
Molecular Genetics and Metabolism. 132:S263-S264
Publikováno v:
Molecular Genetics & Genomic Medicine
Molecular Genetics & Genomic Medicine, Vol 7, Iss 7, Pp n/a-n/a (2019)
Molecular Genetics & Genomic Medicine, Vol 7, Iss 7, Pp n/a-n/a (2019)
Purpose To assess clinical chromosomal microarray (CMA) genomic testing reports for the following: (a) usage of reporting elements consistent with 2011 ACMG guidelines and other elements identified in the primary literature, (b) information quality,
Autor:
Ling Ling, Solange M. Aliaga, Minh Bui, Hope Twede, Rena Vanzo, Michael H. Field, David Francis, David J. Amor, David E. Godler, Jonathon W. Morison, Megan M. Martin, Charles H. Hensel
Publikováno v:
Scientific Reports
Scientific Reports, Vol 9, Iss 1, Pp 1-11 (2019)
Scientific Reports, Vol 9, Iss 1, Pp 1-11 (2019)
In 2016, Methylation-Specific Quantitative Melt Analysis (MS-QMA) on 3,340 male probands increased diagnostic yield from 1.60% to 1.84% for fragile X syndrome (FXS) using a pooling approach. In this study probands from Lineagen (UT, U.S.A.) of both s
Autor:
Aparna Prasad, Hope Twede, Karen S. Ho, Stephanie Page, Kyle W. Davis, E. Robert Wassman, Moises A. Serrano, Andreas Peiffer, Megan M. Martin, Diana Bertrand, Mohammed Uddin, Stephen W. Scherer, Rena Vanzo, Charles H. Hensel
Publikováno v:
Neurology: Genetics
ObjectiveTo evaluate a new tool to aid interpretation of copy number variants (CNVs) in individuals with neurodevelopmental disabilities.MethodsCritical exon indexing (CEI) was used to identify genes with critical exons (CEGs) from clinically reporte
Publikováno v:
Journal of Community Genetics. 6:343-349
Chromosomal microarray is the recommended first-tier genetic test when a child presents with idiopathic developmental delay (DD), intellectual disability (ID), and/or autism spectrum disorder (ASD). Microarray may discover variants of unknown clinica
Publikováno v:
Journal of Genetic Counseling. 24:503-511
Cognitively impaired patients with dementia often rely on health advocates or guardians, such as spouses or adult offspring, to consent for medical procedures. These family members may also decide whether an autopsy is performed after death or whethe
Autor:
Kenneth Ward, Karen S. Ho, Charles H. Hensel, Brynn Levy, Sarah T. South, Rena Vanzo, Edward Robert Wassman, Moises A. Serrano, Sean Dixon, Christophe G. Lambert, Lesa Nelson, Patricia Rushton, Andy Peiffer, Megan M. Martin
Publikováno v:
PLoS Currents
Introduction: Chromosomal microarray analysis (CMA) is recognized as the first-tier test in the genetic evaluation of children with developmental delays, intellectual disabilities, congenital anomalies and autism spectrum disorders of unknown etiolog